Targeting midkine and pleiotrophin signalling pathways in addiction and neurodegenerative disorders: recent progress and perspectives

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|171|4|837-848

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.171, Iss.4, 2014-02, pp. : 837-848

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Midkine and Pleiotrophin in the Treatment of Neurodegenerative Diseases and Drug Addiction

By  

Recent Patents on CNS Drug Discovery, Vol. 10, Iss. 1, 2015-01 ,pp. : 28-33

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders

By  

DRUG DEVELOPMENT RESEARCH, Vol. 76, Iss. 7, 2015-11 ,pp. : 397-418

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dendritic cell specific targeting of MyD88 signalling pathways in vivo

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 1, 2015-01 ,pp. : 32-39

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recent updates and future perspectives in the treatment of electrolyte disorders

By Tzamaloukas Antonios H   Glew Robert H  

Clinical Practice, Vol. 10, Iss. 6, 2013-11 ,pp. : 679-682

Future Medicine

Access to resources Recommend Favorite

Targeting Neurotrophic Signal Transduction Pathways in the Treatment of Mood Disorders

By  

Current Signal Transduction Therapy, Vol. 2, Iss. 2, 2007-05 ,pp. : 101-110

Bentham Science Publishers

Access to resources Recommend Favorite